# Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

> **NCT02785159** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 152 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** IDP-118 Lotion
- **DRUG:** Tazorac Cream
- **DRUG:** IDP-118 Vehicle Lotion
- **DRUG:** IDP-118 Vehicle Cream

## Key facts

- **NCT ID:** NCT02785159
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-11-20
- **Final completion:** 2016-12
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785159, "Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02785159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*